Eli Lilly and Company vs Merck & Co., Inc.
Eli Lilly and Company is worth $1.061T, 2.8× the $377.724B market cap of Merck & Co., Inc.. Updated daily.
| Metric | ||
|---|---|---|
| Market cap | $1.061T | $377.724B |
| Global rank | #1 | #2 |
| Share price | $1,189.41 | $153.10 |
| Change | -2.11% | +17.39% |
| Revenue | $65.179B | $65.011B |
| Net income | $20.640B | $18.254B |
| Country | United States | United States |
| Sector | Healthcare | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Eli Lilly and Company bigger than Merck & Co., Inc.?
- Eli Lilly and Company has a market cap of $1.061T against $377.724B for Merck & Co., Inc., making it 2.8 times as valuable.
- Which company earns more, LLY or MRK?
- Eli Lilly and Company reported net income of $20.640B and Merck & Co., Inc. reported $18.254B in their most recent annual periods.